[1] |
国家卫生健康委员会办公厅国家中医药管理局办公室. 关于印发新型冠状病毒肺炎诊疗方案(试行第九版)的通知[EB/OL].(2022-03-15)[2022-03-16]. http://www.gov.cn/zhengce/zhengceku/2022-03/15/content_5679257.htm.
|
[2] |
国家卫生健康委. 新冠病毒抗原检测应用方案(试行)[EB/OL].(2022-03-12)[2022-04-19]. http://www.nhc.gov.cn/yzygj/s7659/202203/d4d7fb72088447f7a4f9cd10966a67eb.shtml.
|
[3] |
MOLLARASOULI F, ZARE-SHEHNEH N, GHAEDI M. A review on corona virus disease 2019(COVID-19):current progress,clinical features and bioanalytical diagnostic methods[J]. Mikrochim Acta, 2022, 189(3):103.
DOI
URL
|
[4] |
CAI Y, ZHANG J, XIAO T, et al. Distinct conformational states of SARS-CoV-2 spike protein[J]. Science, 2020, 369(6511):1586-1592.
DOI
PMID
|
[5] |
DRAIN P K. Rapid diagnostic testing for SARS-CoV-2[J]. N Engl J Med, 2022, 386(3):264-272.
DOI
URL
|
[6] |
CHE X Y, HAO W, WANG Y, et al. Nucleocapsid protein as early diagnostic marker for SARS[J]. Emerg Infect Dis, 2004, 10(11):1947-1949.
DOI
URL
|
[7] |
ZHANG Y, ONG C M, YUN C, et al. Diagnostic value of nucleocapsid protein in blood for SARS-CoV-2 infection[J]. Clin Chem, 2021, 68(1):240-248.
DOI
PMID
|
[8] |
SOHRABI H, MAJIDI M R, FAKHRAEI M, et al. Lateral flow assays(LFA)for detection of pathogenic bacteria:a small point-of-care platform for diagnosis of human infectious diseases[J]. Talanta, 2022, 243:123330.
DOI
URL
|
[9] |
GRANT B D, ANDERSON C E, WILLIFORD J R, et al. SARS-CoV-2 coronavirus nucleocapsid antigen-detecting half-strip lateral flow assay toward the development of point of care tests using commercially available reagents[J]. Anal Chem, 2020, 92(16):11305-11309.
DOI
PMID
|
[10] |
YAKOH A, PIMPITAK U, RENGPIPAT S, et al. Paper-based electrochemical biosensor for diagnosing COVID-19:detection of SARS-CoV-2 antibodies and antigen[J]. Biosens Bioelectron, 2021, 176:112912.
DOI
URL
|
[11] |
XUE Q, KAN X, PAN Z, et al. An intelligent face mask integrated with high density conductive nanowire array for directly exhaled coronavirus aerosols screening[J]. Biosens Bioelectron, 2021, 186:113286.
DOI
URL
|
[12] |
SCOHY A, ANANTHARAJAH A, BODÉUS M, et al. Low performance of rapid antigen detection test as frontline testing for COVID-19 diagnosis[J]. J Clin Virol, 2020, 129:104455.
DOI
URL
|
[13] |
PORTE L, LEGARRAGA P, VOLLRATH V, et al. Evaluation of a novel antigen-based rapid detection test for the diagnosis of SARS-CoV-2 in respiratory samples[J]. Int J Infect Dis, 2020, 99:328-333.
DOI
PMID
|
[14] |
The Foundation for Innovative New Diagnostics. FIND evaluation of SARS-CoV-2 antigen(Ag)detectingtests[EB/OL].(2022-02-15)[2022-03-15]. https://www.finddx.org/sarscov2-eval-antigen/.
|
[15] |
SCHEIBLAUER H, FILOMENA A, NITSCHE A, et al. Comparative sensitivity evaluation for 122 CE-marked rapid diagnostic tests for SARS-CoV-2 antigen,Germany,September 2020 to April 2021[J]. Euro Surveill, 2021, 26(44):2100441.
|
[16] |
HAAGE V, FERREIRA DE OLIVEIRA-FILHO E, MOREIRA-SOTO A, et al. Impaired performance of SARS-CoV-2 antigen-detecting rapid diagnostic tests at elevated and low temperatures[J]. J Clin Virol, 2021, 138:104796.
DOI
URL
|
[17] |
FILCHAKOVA O, DOSSYM D, ILYAS A, et al. Review of COVID-19 testing and diagnostic methods[J]. Talanta, 2022, 244:123409.
DOI
URL
|
[18] |
DINNES J, DEEKS J J, BERHANE S, et al. Rapid,point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection[J]. Cochrane Database Syst Rev, 2021, 3(3):CD013705.
|
[19] |
SARS-CoV-2 antigen-detecting rapid diagnostic tests:an implementation guide[Z]. Geneva: World Health Organization, 2020.
|
[20] |
中华人民共和国国家卫生和计划生育委员会. WS/T 494-2017 临床定性免疫检验重要常规项目分析质量要求[S]. 北京: 中华人民共和国国家卫生和计划生育委员会, 2017.
|
[21] |
中华人民共和国国家卫生和计划生育委员会. WS/T 505-2017 定性测定性能评价指南[S]. 北京: 中华人民共和国国家卫生和计划生育委员会, 2017.
|
[22] |
CAMERONI E, BOWEN J E, ROSEN L E, et al. Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift[J]. Nature, 2022, 602(7898):664-670.
DOI
URL
|